CDH1 and pulmonary fibrosis: And our experimental results indicated that imrecoxib can reduce the inhibition on E-cadherin and promotion on vimentin in paraquat-induced A549 cells and then inhibit the EMT activated by paraquat, so as to treat paraquat-induced pulmonary fibrosis.